Rosa Di Noto

1.6k citations
43 papers · 1.1k indexed · h-index 21
Topics
Acute Myeloid Leukemia Research (14 papers)Retinoids in leukemia and cellular processes (9 papers)Cancer Cells and Metastasis (7 papers)
Partner nations
ItalyBelgiumFrance

In The Last Decade

Rosa Di Noto

42 papers receiving 1.1k citations

Peers

Rosa Di Noto
Comparison fields: 5 of 93
  • Molecular Biology 517
  • Hematology 377
  • Immunology 210
  • Oncology 207
  • Microbiology 149
Replace Emile van den Akker with:
Emile van den Akker Netherlands
Jordi Félez Spain
Olivier Spertini Switzerland
John Marken United States
H. A. Messner Canada
Paul A. Chervenick United States
EF Winton United States
Joon Seong Park South Korea
Amiel G. Cooper United States
D J Anstee United Kingdom
Rosa Di Noto relative to Emile van den Akker Netherlands Emile van den Akker's profile →
Citations per field
00.5×2.7×
Emile van den Akker · 1×
Citations per year

Countries citing papers authored by Rosa Di Noto

Since Specialization
Citations

This map shows the geographic impact of Rosa Di Noto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosa Di Noto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosa Di Noto more than expected).

Fields of papers citing papers by Rosa Di Noto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosa Di Noto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosa Di Noto. The network helps show where Rosa Di Noto may publish in the future.

Co-authorship network of co-authors of Rosa Di Noto

This figure shows the co-authorship network connecting the top 25 collaborators of Rosa Di Noto. A scholar is included among the top collaborators of Rosa Di Noto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosa Di Noto. Rosa Di Noto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 30
2 16
3 26
4 13
5 10
6 5
7 26
8 13
9 18
10 18
11 30
12 22
13 21
14 17
15 20
16 18
17 4
18 52
19 16
20 40

About Rosa Di Noto

Rosa Di Noto is a scholar working on Hematology, Microbiology and Immunology, having authored 43 papers that have together received 1.1k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (14 papers), Retinoids in leukemia and cellular processes (9 papers) and Cancer Cells and Metastasis (7 papers). The work is most often cited by research in Hematology (377 citations), Microbiology (149 citations) and Genetics (141 citations). Rosa Di Noto has collaborated with scholars based in Italy, Belgium and France. Frequent co-authors include Luigi Del Vecchio, Peppino Mirabelli, Catia Lo Pardo, Felicetto Ferrara, Francesco Salvatore, Ettore Mariano Schiavone, Piernicola Boccuni, Ciro Manzo, Marica Gemei and Bruno Rotoli. Their work appears in journals such as Journal of Clinical Oncology, Cancer and Antimicrobial Agents and Chemotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026